A-003105

N/A

Report date: 2025/01/26 19:34:09
NME

Base Information

Drug NameA-003105
Drug Alias NameA2aR/A2bR checkpoint inhibitor (Arcus Biosciences)A-003105
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAdenosine A2b receptor antagonistsAdenosine A2a receptor antagonists
TargetsAdenosine A2b receptorAdenosine A2a receptor
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesArcus Biosciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesArcus Biosciences Inc
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A